nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1D—meninx—peripheral nervous system neoplasm	0.0398	0.105	CbGeAlD
Methysergide—HTR1F—trigeminal nerve—peripheral nervous system neoplasm	0.0397	0.105	CbGeAlD
Methysergide—HTR1B—dura mater—peripheral nervous system neoplasm	0.0378	0.0998	CbGeAlD
Methysergide—HTR1D—dura mater—peripheral nervous system neoplasm	0.0366	0.0966	CbGeAlD
Methysergide—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0214	0.0564	CbGeAlD
Methysergide—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0163	0.0429	CbGeAlD
Methysergide—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0158	0.0415	CbGeAlD
Methysergide—HTR1F—ganglion—peripheral nervous system neoplasm	0.0143	0.0378	CbGeAlD
Methysergide—HTR7—vagus nerve—peripheral nervous system neoplasm	0.0117	0.0309	CbGeAlD
Methysergide—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0116	0.0306	CbGeAlD
Methysergide—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.0112	0.0296	CbGeAlD
Methysergide—HTR6—ganglion—peripheral nervous system neoplasm	0.00974	0.0257	CbGeAlD
Methysergide—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00894	0.0236	CbGeAlD
Methysergide—HTR7—pons—peripheral nervous system neoplasm	0.00884	0.0233	CbGeAlD
Methysergide—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00783	0.0206	CbGeAlD
Methysergide—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00732	0.0193	CbGeAlD
Methysergide—HTR1B—ganglion—peripheral nervous system neoplasm	0.00587	0.0155	CbGeAlD
Methysergide—HTR1D—ganglion—peripheral nervous system neoplasm	0.00568	0.015	CbGeAlD
Methysergide—HTR2C—ganglion—peripheral nervous system neoplasm	0.00563	0.0148	CbGeAlD
Methysergide—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00558	0.0147	CbGeAlD
Methysergide—HTR2A—pons—peripheral nervous system neoplasm	0.00551	0.0145	CbGeAlD
Methysergide—HTR1E—brainstem—peripheral nervous system neoplasm	0.00539	0.0142	CbGeAlD
Methysergide—HTR1A—ganglion—peripheral nervous system neoplasm	0.00474	0.0125	CbGeAlD
Methysergide—HTR7—nerve—peripheral nervous system neoplasm	0.00458	0.0121	CbGeAlD
Methysergide—HTR7—ganglion—peripheral nervous system neoplasm	0.00453	0.0119	CbGeAlD
Methysergide—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00288	0.0076	CbGeAlD
Methysergide—HTR2A—nerve—peripheral nervous system neoplasm	0.00286	0.00753	CbGeAlD
Methysergide—HTR2A—ganglion—peripheral nervous system neoplasm	0.00282	0.00744	CbGeAlD
Methysergide—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00279	0.00736	CbGeAlD
Methysergide—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.0026	0.00686	CbGeAlD
Methysergide—HTR1B—brainstem—peripheral nervous system neoplasm	0.00255	0.00672	CbGeAlD
Methysergide—HTR1D—brainstem—peripheral nervous system neoplasm	0.00247	0.00651	CbGeAlD
Methysergide—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.00245	0.00647	CbGeAlD
Methysergide—HTR2C—brainstem—peripheral nervous system neoplasm	0.00245	0.00645	CbGeAlD
Methysergide—Ergonovine—ABCB1—peripheral nervous system neoplasm	0.00218	0.475	CrCbGaD
Methysergide—HTR1A—brainstem—peripheral nervous system neoplasm	0.00206	0.00543	CbGeAlD
Methysergide—HTR7—brainstem—peripheral nervous system neoplasm	0.00197	0.00519	CbGeAlD
Methysergide—Ergotamine—ABCB1—peripheral nervous system neoplasm	0.00123	0.267	CrCbGaD
Methysergide—HTR2A—brainstem—peripheral nervous system neoplasm	0.00123	0.00323	CbGeAlD
Methysergide—Bromocriptine—ABCB1—peripheral nervous system neoplasm	0.00118	0.258	CrCbGaD
Methysergide—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.00114	0.00299	CbGeAlD
Methysergide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00103	0.00189	CcSEcCtD
Methysergide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00103	0.00189	CcSEcCtD
Methysergide—Pain—Melphalan—peripheral nervous system neoplasm	0.00102	0.00187	CcSEcCtD
Methysergide—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00187	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00187	CcSEcCtD
Methysergide—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00101	0.00268	CbGeAlD
Methysergide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00186	CcSEcCtD
Methysergide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00101	0.00184	CcSEcCtD
Methysergide—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000999	0.00183	CcSEcCtD
Methysergide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000998	0.00183	CcSEcCtD
Methysergide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000998	0.00183	CcSEcCtD
Methysergide—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000991	0.00181	CcSEcCtD
Methysergide—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000991	0.00181	CcSEcCtD
Methysergide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00099	0.00181	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.000984	0.0018	CcSEcCtD
Methysergide—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000975	0.00178	CcSEcCtD
Methysergide—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000973	0.00178	CcSEcCtD
Methysergide—HTR7—cerebellum—peripheral nervous system neoplasm	0.00097	0.00256	CbGeAlD
Methysergide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000969	0.00177	CcSEcCtD
Methysergide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000965	0.00177	CcSEcCtD
Methysergide—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000965	0.00177	CcSEcCtD
Methysergide—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000958	0.00175	CcSEcCtD
Methysergide—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.00173	CcSEcCtD
Methysergide—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000944	0.00173	CcSEcCtD
Methysergide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000939	0.00172	CcSEcCtD
Methysergide—Flushing—Etoposide—peripheral nervous system neoplasm	0.000936	0.00171	CcSEcCtD
Methysergide—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000923	0.00169	CcSEcCtD
Methysergide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.00168	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000902	0.00165	CcSEcCtD
Methysergide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000899	0.00165	CcSEcCtD
Methysergide—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.00164	CcSEcCtD
Methysergide—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000891	0.00163	CcSEcCtD
Methysergide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000889	0.00163	CcSEcCtD
Methysergide—Oedema—Vincristine—peripheral nervous system neoplasm	0.000885	0.00162	CcSEcCtD
Methysergide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000876	0.0016	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.0016	CcSEcCtD
Methysergide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000869	0.00159	CcSEcCtD
Methysergide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000869	0.00159	CcSEcCtD
Methysergide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000866	0.00159	CcSEcCtD
Methysergide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000864	0.00158	CcSEcCtD
Methysergide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000858	0.00157	CcSEcCtD
Methysergide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000854	0.00156	CcSEcCtD
Methysergide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000849	0.00155	CcSEcCtD
Methysergide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000847	0.00155	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000836	0.00153	CcSEcCtD
Methysergide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000836	0.00153	CcSEcCtD
Methysergide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00083	0.00152	CcSEcCtD
Methysergide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00083	0.00152	CcSEcCtD
Methysergide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000829	0.00152	CcSEcCtD
Methysergide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000829	0.00152	CcSEcCtD
Methysergide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.00151	CcSEcCtD
Methysergide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.0015	CcSEcCtD
Methysergide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000818	0.0015	CcSEcCtD
Methysergide—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000817	0.0015	CcSEcCtD
Methysergide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000816	0.00149	CcSEcCtD
Methysergide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000816	0.00149	CcSEcCtD
Methysergide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000816	0.00149	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000815	0.00149	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00081	0.00148	CcSEcCtD
Methysergide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000808	0.00148	CcSEcCtD
Methysergide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000808	0.00148	CcSEcCtD
Methysergide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000806	0.00148	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000806	0.00148	CcSEcCtD
Methysergide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000801	0.00147	CcSEcCtD
Methysergide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.00147	CcSEcCtD
Methysergide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.0008	0.00146	CcSEcCtD
Methysergide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000794	0.00145	CcSEcCtD
Methysergide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.00145	CcSEcCtD
Methysergide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000792	0.00145	CcSEcCtD
Methysergide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000792	0.00145	CcSEcCtD
Methysergide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000785	0.00144	CcSEcCtD
Methysergide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000785	0.00144	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000783	0.00143	CcSEcCtD
Methysergide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000783	0.00143	CcSEcCtD
Methysergide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000782	0.00143	CcSEcCtD
Methysergide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000776	0.00142	CcSEcCtD
Methysergide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00141	CcSEcCtD
Methysergide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00141	CcSEcCtD
Methysergide—Rash—Topotecan—peripheral nervous system neoplasm	0.00077	0.00141	CcSEcCtD
Methysergide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000769	0.00141	CcSEcCtD
Methysergide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000769	0.00141	CcSEcCtD
Methysergide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000766	0.0014	CcSEcCtD
Methysergide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000764	0.0014	CcSEcCtD
Methysergide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000764	0.0014	CcSEcCtD
Methysergide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000764	0.0014	CcSEcCtD
Methysergide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000763	0.0014	CcSEcCtD
Methysergide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000763	0.0014	CcSEcCtD
Methysergide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000763	0.0014	CcSEcCtD
Methysergide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000763	0.0014	CcSEcCtD
Methysergide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000761	0.00139	CcSEcCtD
Methysergide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00076	0.00139	CcSEcCtD
Methysergide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000757	0.00138	CcSEcCtD
Methysergide—Pain—Vincristine—peripheral nervous system neoplasm	0.000757	0.00138	CcSEcCtD
Methysergide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000757	0.00138	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.00138	CcSEcCtD
Methysergide—Rash—Melphalan—peripheral nervous system neoplasm	0.000754	0.00138	CcSEcCtD
Methysergide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000753	0.00138	CcSEcCtD
Methysergide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000751	0.00137	CcSEcCtD
Methysergide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000748	0.00137	CcSEcCtD
Methysergide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000747	0.00137	CcSEcCtD
Methysergide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000739	0.00135	CcSEcCtD
Methysergide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000726	0.00133	CcSEcCtD
Methysergide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000726	0.00133	CcSEcCtD
Methysergide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000725	0.00133	CcSEcCtD
Methysergide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000723	0.00132	CcSEcCtD
Methysergide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00072	0.00132	CcSEcCtD
Methysergide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00072	0.00132	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000713	0.0013	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.0013	CcSEcCtD
Methysergide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00071	0.0013	CcSEcCtD
Methysergide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00071	0.0013	CcSEcCtD
Methysergide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000702	0.00129	CcSEcCtD
Methysergide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000702	0.00128	CcSEcCtD
Methysergide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000699	0.00128	CcSEcCtD
Methysergide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000699	0.00128	CcSEcCtD
Methysergide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000699	0.00128	CcSEcCtD
Methysergide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000699	0.00128	CcSEcCtD
Methysergide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000697	0.00128	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.00126	CcSEcCtD
Methysergide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000677	0.00124	CcSEcCtD
Methysergide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000675	0.00124	CcSEcCtD
Methysergide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000669	0.00122	CcSEcCtD
Methysergide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000661	0.00121	CcSEcCtD
Methysergide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000661	0.00121	CcSEcCtD
Methysergide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000659	0.00121	CcSEcCtD
Methysergide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.00118	CcSEcCtD
Methysergide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000645	0.00118	CcSEcCtD
Methysergide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000644	0.00118	CcSEcCtD
Methysergide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000643	0.00118	CcSEcCtD
Methysergide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000639	0.00117	CcSEcCtD
Methysergide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000639	0.00117	CcSEcCtD
Methysergide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000637	0.00117	CcSEcCtD
Methysergide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000635	0.00116	CcSEcCtD
Methysergide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00063	0.00115	CcSEcCtD
Methysergide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00063	0.00115	CcSEcCtD
Methysergide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.00115	CcSEcCtD
Methysergide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000624	0.00114	CcSEcCtD
Methysergide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000619	0.00113	CcSEcCtD
Methysergide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000618	0.00113	CcSEcCtD
Methysergide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000618	0.00113	CcSEcCtD
Methysergide—Pain—Etoposide—peripheral nervous system neoplasm	0.000613	0.00112	CcSEcCtD
Methysergide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000613	0.00112	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000611	0.00112	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000611	0.00112	CcSEcCtD
Methysergide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00111	CcSEcCtD
Methysergide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000605	0.00111	CcSEcCtD
Methysergide—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000605	0.00159	CbGeAlD
Methysergide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.00109	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.00108	CcSEcCtD
Methysergide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000591	0.00108	CcSEcCtD
Methysergide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.00108	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000586	0.00107	CcSEcCtD
Methysergide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000585	0.00107	CcSEcCtD
Methysergide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.00107	CcSEcCtD
Methysergide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000583	0.00107	CcSEcCtD
Methysergide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000579	0.00106	CcSEcCtD
Methysergide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00106	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000567	0.00104	CcSEcCtD
Methysergide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000567	0.00104	CcSEcCtD
Methysergide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000562	0.00103	CcSEcCtD
Methysergide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000561	0.00103	CcSEcCtD
Methysergide—Rash—Vincristine—peripheral nervous system neoplasm	0.000558	0.00102	CcSEcCtD
Methysergide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000557	0.00102	CcSEcCtD
Methysergide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000557	0.00102	CcSEcCtD
Methysergide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.000998	CcSEcCtD
Methysergide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000535	0.00098	CcSEcCtD
Methysergide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000525	0.000962	CcSEcCtD
Methysergide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00096	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000943	CcSEcCtD
Methysergide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000514	0.000941	CcSEcCtD
Methysergide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000914	CcSEcCtD
Methysergide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000497	0.00091	CcSEcCtD
Methysergide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000493	0.000903	CcSEcCtD
Methysergide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000493	0.000902	CcSEcCtD
Methysergide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00049	0.000897	CcSEcCtD
Methysergide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000889	CcSEcCtD
Methysergide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000871	CcSEcCtD
Methysergide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000474	0.000867	CcSEcCtD
Methysergide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00085	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000846	CcSEcCtD
Methysergide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000457	0.000836	CcSEcCtD
Methysergide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000456	0.000834	CcSEcCtD
Methysergide—Rash—Etoposide—peripheral nervous system neoplasm	0.000452	0.000827	CcSEcCtD
Methysergide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000451	0.000826	CcSEcCtD
Methysergide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000812	CcSEcCtD
Methysergide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000806	CcSEcCtD
Methysergide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00078	CcSEcCtD
Methysergide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000426	0.000779	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000423	0.000773	CcSEcCtD
Methysergide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000767	CcSEcCtD
Methysergide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000767	CcSEcCtD
Methysergide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000767	CcSEcCtD
Methysergide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000758	CcSEcCtD
Methysergide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000752	CcSEcCtD
Methysergide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000735	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000722	CcSEcCtD
Methysergide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00072	CcSEcCtD
Methysergide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000718	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.00071	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.00071	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.00071	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000701	CcSEcCtD
Methysergide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.00068	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000366	0.00067	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000666	CcSEcCtD
Methysergide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000665	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000664	CcSEcCtD
Methysergide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00066	CcSEcCtD
Methysergide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000655	CcSEcCtD
Methysergide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000654	CcSEcCtD
Methysergide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000647	CcSEcCtD
Methysergide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000635	CcSEcCtD
Methysergide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000634	CcSEcCtD
Methysergide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000629	CcSEcCtD
Methysergide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000629	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00062	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000615	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000611	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000606	CcSEcCtD
Methysergide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000606	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000605	CcSEcCtD
Methysergide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000601	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000599	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000587	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000586	CcSEcCtD
Methysergide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000582	CcSEcCtD
Methysergide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000582	CcSEcCtD
Methysergide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000581	CcSEcCtD
Methysergide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000581	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000561	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000556	CcSEcCtD
Methysergide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000538	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000538	CcSEcCtD
Methysergide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000527	CcSEcCtD
Methysergide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000503	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000488	CcSEcCtD
Methysergide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000486	CcSEcCtD
Methysergide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000467	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000465	CcSEcCtD
Methysergide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000464	CcSEcCtD
Methysergide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000463	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00045	CcSEcCtD
Methysergide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000437	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000433	CcSEcCtD
Methysergide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000429	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000429	CcSEcCtD
Methysergide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000404	CcSEcCtD
Methysergide—HTR1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000101	0.00145	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0001	0.00144	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.99e-05	0.00144	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.98e-05	0.00143	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.95e-05	0.00143	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.91e-05	0.00142	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.9e-05	0.00142	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.88e-05	0.00142	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.87e-05	0.00142	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.84e-05	0.00141	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.71e-05	0.00139	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.51e-05	0.00137	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.41e-05	0.00135	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	9.14e-05	0.00131	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.13e-05	0.00131	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.12e-05	0.00131	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.09e-05	0.00131	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.73e-05	0.00125	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.72e-05	0.00125	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.66e-05	0.00124	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.64e-05	0.00124	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.55e-05	0.00123	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.49e-05	0.00122	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.48e-05	0.00122	CbGpPWpGaD
Methysergide—HTR7—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	8.07e-05	0.00116	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.01e-05	0.00115	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.97e-05	0.00114	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.93e-05	0.00114	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.92e-05	0.00114	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.9e-05	0.00113	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.89e-05	0.00113	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.89e-05	0.00113	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.87e-05	0.00113	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.84e-05	0.00113	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.71e-05	0.00111	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.7e-05	0.00111	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.67e-05	0.0011	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.67e-05	0.0011	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.63e-05	0.0011	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.62e-05	0.0011	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.57e-05	0.00109	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.47e-05	0.00107	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.42e-05	0.00107	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.4e-05	0.00106	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.37e-05	0.00106	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.36e-05	0.00106	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.29e-05	0.00105	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.28e-05	0.00105	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.27e-05	0.00104	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.24e-05	0.00104	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.23e-05	0.00104	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.21e-05	0.00104	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.08e-05	0.00102	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.05e-05	0.00101	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.97e-05	0.001	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.93e-05	0.000996	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.92e-05	0.000995	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.92e-05	0.000994	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.88e-05	0.000988	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.85e-05	0.000985	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.73e-05	0.000967	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.68e-05	0.00096	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.66e-05	0.000957	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.65e-05	0.000956	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.53e-05	0.000938	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.46e-05	0.000928	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.43e-05	0.000923	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.4e-05	0.000919	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.39e-05	0.000918	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.35e-05	0.000913	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.33e-05	0.000909	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.99e-05	0.000861	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.87e-05	0.000843	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.85e-05	0.00084	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.84e-05	0.000838	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.82e-05	0.000835	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.65e-05	0.000812	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.62e-05	0.000807	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.58e-05	0.000802	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.47e-05	0.000786	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.47e-05	0.000785	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.43e-05	0.00078	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.39e-05	0.000775	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.39e-05	0.000774	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.37e-05	0.000771	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.32e-05	0.000764	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.13e-05	0.000737	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.1e-05	0.000733	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.07e-05	0.000728	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.05e-05	0.000725	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5e-05	0.000718	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.88e-05	0.000701	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.82e-05	0.000692	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.81e-05	0.000691	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.78e-05	0.000687	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.68e-05	0.000673	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.68e-05	0.000673	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.68e-05	0.000672	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.68e-05	0.000672	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.66e-05	0.000669	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.65e-05	0.000667	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.55e-05	0.000654	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.49e-05	0.000646	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.46e-05	0.000641	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.46e-05	0.00064	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.43e-05	0.000637	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.43e-05	0.000636	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.42e-05	0.000634	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.4e-05	0.000632	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.34e-05	0.000623	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.27e-05	0.000614	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.24e-05	0.000609	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.17e-05	0.000598	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.09e-05	0.000588	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.09e-05	0.000587	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.07e-05	0.000585	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.06e-05	0.000584	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.05e-05	0.000582	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.03e-05	0.000579	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.98e-05	0.000571	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.74e-05	0.000537	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.57e-05	0.000512	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.55e-05	0.000509	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.5e-05	0.000503	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.49e-05	0.000501	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.47e-05	0.000498	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.45e-05	0.000495	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.3e-05	0.000474	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.29e-05	0.000473	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.29e-05	0.000472	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.29e-05	0.000472	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.2e-05	0.000459	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.17e-05	0.000455	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.1e-05	0.000446	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.08e-05	0.000442	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.03e-05	0.000435	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.02e-05	0.000433	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.02e-05	0.000433	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.99e-05	0.00043	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.99e-05	0.000429	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.9e-05	0.000417	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.9e-05	0.000416	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.89e-05	0.000416	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.87e-05	0.000413	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.85e-05	0.00041	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.85e-05	0.000409	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.84e-05	0.000408	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.82e-05	0.000406	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.81e-05	0.000404	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.76e-05	0.000397	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.74e-05	0.000393	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.65e-05	0.000381	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.64e-05	0.00038	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.62e-05	0.000376	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.6e-05	0.000373	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.5e-05	0.00036	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.47e-05	0.000355	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.33e-05	0.000335	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.25e-05	0.000323	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.25e-05	0.000323	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.23e-05	0.000321	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.19e-05	0.000314	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.14e-05	0.000308	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.13e-05	0.000306	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.12e-05	0.000304	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.12e-05	0.000304	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.11e-05	0.000303	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.1e-05	0.000302	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.1e-05	0.000301	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000296	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.06e-05	0.000296	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000296	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.05e-05	0.000295	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.04e-05	0.000294	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.04e-05	0.000293	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.04e-05	0.000293	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.03e-05	0.000292	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.03e-05	0.000291	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2e-05	0.000288	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.98e-05	0.000285	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.94e-05	0.000279	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.93e-05	0.000278	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.92e-05	0.000275	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.88e-05	0.00027	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.87e-05	0.000269	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.87e-05	0.000268	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.86e-05	0.000268	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.86e-05	0.000267	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.85e-05	0.000266	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.83e-05	0.000263	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.82e-05	0.000261	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.82e-05	0.000261	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.72e-05	0.000246	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.71e-05	0.000246	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.71e-05	0.000245	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000245	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.7e-05	0.000244	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.66e-05	0.000239	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.66e-05	0.000239	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.66e-05	0.000238	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000232	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.59e-05	0.000229	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.59e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.58e-05	0.000227	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-05	0.000225	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.56e-05	0.000224	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.56e-05	0.000224	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.55e-05	0.000222	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000219	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000218	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-05	0.000217	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.5e-05	0.000216	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.45e-05	0.000209	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.44e-05	0.000207	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000199	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000198	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000195	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000189	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.31e-05	0.000188	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.31e-05	0.000188	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.31e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.3e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.27e-05	0.000183	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000182	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.26e-05	0.000181	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.25e-05	0.00018	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.25e-05	0.00018	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.24e-05	0.000178	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000175	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000172	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.19e-05	0.000172	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-05	0.000169	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.17e-05	0.000169	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000164	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000159	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000159	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000158	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.09e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000154	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.02e-05	0.000146	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000145	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.69e-06	0.000139	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.64e-06	0.000138	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.26e-06	0.000133	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.22e-06	0.000132	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.37e-06	0.00012	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.18e-06	0.000118	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.14e-06	0.000117	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8e-06	0.000115	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.07e-06	0.000102	CbGpPWpGaD
